Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H22ClN3O3S |
| Molecular Weight | 347.861 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1CCCC1CNS(=O)(=O)C2=C(OC)C=C(N)C(Cl)=C2
InChI
InChIKey=YSWVLPFCGJOQQA-UHFFFAOYSA-N
InChI=1S/C14H22ClN3O3S/c1-3-18-6-4-5-10(18)9-17-22(19,20)14-7-11(15)12(16)8-13(14)21-2/h7-8,10,17H,3-6,9,16H2,1-2H3
| Molecular Formula | C14H22ClN3O3S |
| Molecular Weight | 347.861 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Lorapride is a centrally acting sulfonamide. It has pharmacodynamic properties that are mainly related to ulcer treatment. On the basis of its psychopharmacologic profile, it has no neuroleptic potential, but it does exhibit some psychostimulating components. After oral administration, absorption of lorapride was rapid. The rate of absorption was first order for solution and zero order for capsule.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:56:32 GMT 2023
by
admin
on
Sat Dec 16 16:56:32 GMT 2023
|
| Record UNII |
549TIC7B4R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
68881
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
4909
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
68677-06-5
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105073
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
C81599
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
C047748
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
549TIC7B4R
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
DTXSID50867706
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
100000082011
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
SUB08580MIG
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY | |||
|
272-057-1
Created by
admin on Sat Dec 16 16:56:32 GMT 2023 , Edited by admin on Sat Dec 16 16:56:32 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
